challenges hampering clinical utility of fluid biomarkers in parkinson’s disease
Published 3 years ago • 42 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
2:02
the current use of biomarkers in parkinson’s disease
-
4:05
biofluid and genetic biomarkers for parkinson’s disease
-
4:49
diagnostic utility of csf biomarkers in patients with rapidly progressive dementia
-
1:49
advances in parkinson's disease biomarkers
-
2:00
genetic biomarkers could aid parkinson’s disease diagnosis and guide treatment decisions
-
1:13
elucidating prognostic biomarkers in parkinson’s disease
-
7:35
the power of biomarkers: movement disorders
-
3:07
parkinson’s disease: key updates in imaging biomarkers
-
1:19
analysis of neurotransmitter metabolites in csf in parkinson's disease
-
32:39
biomarkers for parkinson's disease | 2019 udall center research symposium
-
2:08
identification of novel proteomic biomarkers in parkinson's disease
-
3:07
α-synuclein conformation as a novel blood biomarker in parkinson’s disease
-
4:00
peripheral α-synuclein as a parkinson’s disease biomarker
-
1:56
challenges in biomarker development for alzheimer’s disease
-
0:50
csf biomarkers versus blood biomarkers for the early diagnosis of alzheimer’s disease
-
1:39
advancing diagnosis in parkinson’s disease: the search for a reliable biomarker
-
9:31
challenges faced in early parkinson’s disease management and the resurgence of levodopa
-
56:06
biomarkers of neuroinflammation in parkinson’s disease
-
1:18:21
parkinson’s disease: the search for biomarkers